全文获取类型
收费全文 | 197827篇 |
免费 | 35224篇 |
国内免费 | 2619篇 |
专业分类
耳鼻咽喉 | 5768篇 |
儿科学 | 6503篇 |
妇产科学 | 3697篇 |
基础医学 | 10042篇 |
口腔科学 | 2977篇 |
临床医学 | 31875篇 |
内科学 | 57003篇 |
皮肤病学 | 8071篇 |
神经病学 | 19664篇 |
特种医学 | 8195篇 |
外科学 | 46948篇 |
综合类 | 564篇 |
现状与发展 | 72篇 |
一般理论 | 47篇 |
预防医学 | 10478篇 |
眼科学 | 4156篇 |
药学 | 4371篇 |
1篇 | |
中国医学 | 66篇 |
肿瘤学 | 15172篇 |
出版年
2023年 | 5034篇 |
2022年 | 1342篇 |
2021年 | 3982篇 |
2020年 | 6684篇 |
2019年 | 3096篇 |
2018年 | 8453篇 |
2017年 | 8282篇 |
2016年 | 9558篇 |
2015年 | 9608篇 |
2014年 | 17079篇 |
2013年 | 17957篇 |
2012年 | 9172篇 |
2011年 | 9384篇 |
2010年 | 12570篇 |
2009年 | 16242篇 |
2008年 | 9001篇 |
2007年 | 7553篇 |
2006年 | 9642篇 |
2005年 | 7005篇 |
2004年 | 6014篇 |
2003年 | 4771篇 |
2002年 | 4633篇 |
2001年 | 4238篇 |
2000年 | 3373篇 |
1999年 | 3666篇 |
1998年 | 4077篇 |
1997年 | 3753篇 |
1996年 | 3661篇 |
1995年 | 3526篇 |
1994年 | 2244篇 |
1993年 | 1871篇 |
1992年 | 1630篇 |
1991年 | 1659篇 |
1990年 | 1295篇 |
1989年 | 1436篇 |
1988年 | 1245篇 |
1987年 | 1029篇 |
1986年 | 1084篇 |
1985年 | 936篇 |
1984年 | 741篇 |
1983年 | 687篇 |
1982年 | 704篇 |
1981年 | 557篇 |
1980年 | 498篇 |
1979年 | 434篇 |
1978年 | 456篇 |
1977年 | 544篇 |
1976年 | 342篇 |
1975年 | 401篇 |
1972年 | 341篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Robert J. Motzer MD David F. McDermott MD Bernard Escudier MD Mauricio Burotto MD Toni K. Choueiri MD Hans J. Hammers MD PhD Philippe Barthélémy MD PhD Elizabeth R. Plimack MD Camillo Porta MD Saby George MD Thomas Powles MD Frede Donskov MD PhD Howard Gurney MD Christian K. Kollmannsberger MD Marc-Oliver Grimm MD Carlos Barrios MD Yoshihiko Tomita MD PhD Daniel Castellano MD Viktor Grünwald MD PhD Brian I. Rini MD M. Brent McHenry PhD Chung-Wei Lee MD PhD Jennifer McCarthy MA Flavia Ejzykowicz PhD Nizar M. Tannir MD 《Cancer》2022,128(11):2085-2097
22.
23.
24.
Georgios D. Lianos MD PhD Maximos Frountzas MD MPA PhD Dimitrios Schizas MD PhD Evangelos G. Baltagiannis MD George A. Alexiou MD PhD Christina Bali MD PhD Georgios K. Glantzounis MD PhD Michail Mitsis MD PhD Konstantinos Vlachos MD PhD 《Journal of surgical oncology》2023,127(1):7-10
During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered. 相似文献
25.
Kari Hemminki Kristina Sundquist Jan Sundquist Asta Försti Vaclav Liska Akseli Hemminki Xinjun Li 《International journal of cancer. Journal international du cancer》2023,152(6):1107-1114
Many environmental risk factors for hepatobiliary cancers are known but whether they are associated with specific cancer types is unclear. We present here a novel approach of assessing standardized incidence ratios (SIRs) of previously diagnosed comorbidities for hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cholangiocarcinoma (CCA) and ampullary cancer. The 13 comorbidities included alcohol and nonalcohol related liver disease, chronic obstructive pulmonary disease, gallstone disease, viral and other kinds of hepatitis, infection of bile ducts, hepatic and other autoimmune diseases, obesity and diabetes. Patients were identified from the Swedish Inpatient Register from 1987 to 2018, and their cancers were followed from 1997 onwards. SIRs for HCC were 80 to 100 in men and women diagnosed with hepatitis C virus and they were also >10 in patients diagnosed with hepatitis B virus, other kind of hepatitis, hepatic autoimmune disease and nonalcohol related liver disease. Many of these risks, as well as alcohol related liver disease, were either specific to HCC or were shared with intrahepatic CCA. For GBC, CCA and ampullary cancer infection of bile ducts was the main risk factor. Gallstone disease, nonhepatic autoimmune diseases and diabetes were associated with all hepatobiliary cancers. The limitations of the study include inability to cover some rare risk factors and limited follow-up time. Many of the considered comorbidities are characterized by chronic inflammation and/or overt immune disturbance in autoimmune diseases. The results suggest that local chronic inflammation and a related immune disturbance is the carcinogenic trigger for all these cancers. 相似文献
26.
27.
28.
29.
30.
Brede H. Eschliman MPH Hongmai H. Pham MD PhD Amol S. Navathe MD PhD Karen M. Dale BSN MSN Julian Harris MD MBA 《Health services research》2023,58(Z3):311-317